×
About 1,258 results

ALLMedicine™ Hereditary Hemorrhagic Telangiectasia Center

Research & Reviews  467 results

Injection of cyanoacrylate glue for hereditary hemorrhagic telangiectasia.
https://doi.org/10.1002/alr.23017
International Forum of Allergy & Rhinology; Anciaux M, Lebreton JP et. al.

May 7th, 2022 - Injection of cyanoacrylate glue for hereditary hemorrhagic telangiectasia.|2022|Anciaux M,Lebreton JP,Tonnerre D,Leclerc J,Dufour X,|

Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis...
https://doi.org/10.1016/j.gie.2022.02.044
Gastrointestinal Endoscopy; Boland CR, Idos GE et. al.

Apr 30th, 2022 - The gastrointestinal hamartomatous polyposis syndromes are rare, autosomal dominant disorders associated with an increased risk of benign and malignant intestinal and extraintestinal tumors. They include Peutz-Jeghers syndrome, juvenile polyposis ...

Combined transarterial and transvenous embolization of multi-hole pial arteriovenous fi...
https://doi.org/10.1177/19714009221096829
The Neuroradiology Journal; Yamada H, Akiyama T et. al.

Apr 29th, 2022 - Pial arteriovenous fistula (AVF) is a vascular fistulous disease in which the cerebral pial artery and vein are directly connected without the intervening nidus within a sub-pial space. Multi-hole pial AVFs, wherein multiple feeders flow into one ...

Diagnosis and Management of Cancer Risk in the Gastrointestinal Hamartomatous Polyposis...
https://doi.org/10.14309/ajg.0000000000001755
The American Journal of Gastroenterology; Boland CR, Idos GE et. al.

Apr 27th, 2022 - The gastrointestinal hamartomatous polyposis syndromes are rare, autosomal dominant disorders associated with an increased risk of benign and malignant intestinal and extraintestinal tumors. They include Peutz-Jeghers syndrome, juvenile polyposis ...

Doxycycline for bleeding in hereditary hemorrhagic telangiectasia: When low-hanging fru...
https://doi.org/10.1111/jth.15675
Journal of Thrombosis and Haemostasis : JTH; Al-Samkari H

Apr 22nd, 2022 - Doxycycline for bleeding in hereditary hemorrhagic telangiectasia: When low-hanging fruit meets inconvenient data.|2022|Al-Samkari H,|complications,diagnosis,drug therapy,

see more →

Guidelines  3 results

Diagnosis and management of cancer risk in the gastrointestinal hamartomatous polyposis...
https://doi.org/10.1016/j.gie.2022.02.044
Gastrointestinal Endoscopy; Boland CR, Idos GE et. al.

Apr 30th, 2022 - The gastrointestinal hamartomatous polyposis syndromes are rare, autosomal dominant disorders associated with an increased risk of benign and malignant intestinal and extraintestinal tumors. They include Peutz-Jeghers syndrome, juvenile polyposis ...

Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrha...
https://doi.org/10.7326/M20-1443
Annals of Internal Medicine; Faughnan ME, Mager JJ et. al.

Sep 8th, 2020 - Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease with an estimated prevalence of 1 in 5000 that is characterized by the presence of vascular malformations (VMs). These result in chronic bleeding, acute hemorrhage, and c...

Hereditary hemorrhagic telangiectasia and liver involvement: Vascular liver diseases: p...
https://doi.org/10.1016/j.clinre.2020.03.008
Clinics and Research in Hepatology and Gastroenterology; Silvain C, Thévenot T et. al.

Apr 7th, 2020 - Hereditary hemorrhagic telangiectasia and liver involvement: Vascular liver diseases: position papers from the francophone network for vascular liver diseases, the French Association for the Study of the Liver (AFEF), and ERN-rare liver.|2020|Silv...

see more →

Clinicaltrials.gov  14 results

Hereditary Hemorrhagic Telangiectasia (HHT) Research Outcomes Registry
https://clinicaltrials.gov/ct2/show/NCT04150822

Nov 22nd, 2021 - Background and Rationale HHT has an estimated prevalence of 1 in 5000, affecting children and adults, in multiple organs. The disease is characterized by the presence of vascular malformations (VMs), including arteriovenous malformations (AVMs) of...

The ELLIPSE Study: A Phase-1 Study Evaluating the Tolerance of Bevacizumab Nasal Spray to Treat Epistaxis in Hereditary Hemorrhagic Telangiectasia
https://clinicaltrials.gov/ct2/show/NCT01507480

Oct 19th, 2021 - Antiangiogenic drugs, such as bevacizumab, are a new treatment strategy in Hereditary Hemorrhagic Telangiectasia (HHT). Its systemic administration in patients with HHT improves liver damage-related symptoms and epistaxis (cases reported and on-go...

Timolol Gel for Epistaxis in Hereditary Hemorrhagic Telangiectasia
https://clinicaltrials.gov/ct2/show/NCT04139018

Aug 24th, 2021 - This study is a double-blinded, placebo-controlled, 8-week randomized clinical trial investigating the efficacy of timolol gel in the management of epistaxis in adults with HHT. The Specific Aims are to determine in adults with HHT-associated epis...

Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study
https://clinicaltrials.gov/ct2/show/NCT02287558

Jul 15th, 2020 - This is a single-arm, open-label study that will investigate the efficacy and safety profile of pomalidomide in patients with genetically-documented Hereditary Hemorrhagic Telangiectasia (defined by characteristic mutations in Eng, Alk-1 or Smad-4...

Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT)
https://clinicaltrials.gov/ct2/show/NCT02638012

May 28th, 2020 - Hereditary hemorrhagic telangiectasia (HHT), also known as Osler-Weber-Rendu syndrome, is an autosomal dominant disorder that is characterized by abnormal blood vessel development. This dysplasia manifests as mucocutaneous telangiectases and visce...

see more →

News  18 results

Bilateral palmar rash
https://www.mdedge.com/familymedicine/article/253507/dermatology/bilateral-palmar-rash
MDedge Family Medicine;

Apr 6th, 2022 - A biopsy was performed and the pathology report showed ectatic, thin-walled vessels consistent with telangiectasias. There were no other inflammatory, infectious, or malignant changes.

Second International Hereditary Hemorrhagic Telangiectasia (HHT) Guidelines (2020)
https://reference.medscape.com/viewarticle/938166

Sep 30th, 2020 - The Second International Hereditary Hemorrhagic Telangiectasia (HHT) Guidelines were published on September 8, 2020.[1] Management of Epistaxis To reduce HHT-related epistaxis, use moisturizing topical therapies that humidify the nasal mucosa. Con...

Second International Hereditary Hemorrhagic Telangiectasia (HHT) Guidelines (2020)
https://reference.staging.medscape.com/viewarticle/938166

Sep 30th, 2020 - The Second International Hereditary Hemorrhagic Telangiectasia (HHT) Guidelines were published on September 8, 2020.[1] Management of Epistaxis To reduce HHT-related epistaxis, use moisturizing topical therapies that humidify the nasal mucosa. Con...

New Guidelines Expand Management Options for Hereditary Hemorrhagic Telangiectasia
https://www.staging.medscape.com/viewarticle/937096

Sep 10th, 2020 - NEW YORK (Reuters Health) - New guidelines provide updated advice on managing epistaxis and vascular malformations and new recommendations for managing gastrointestinal (GI) bleeding, anemia, pediatric care, and pregnancy and delivery. The expert ...

New Guidelines Expand Management Options for Hereditary Hemorrhagic Telangiectasia
https://www.medscape.com/viewarticle/937096

Sep 10th, 2020 - NEW YORK (Reuters Health) - New guidelines provide updated advice on managing epistaxis and vascular malformations and new recommendations for managing gastrointestinal (GI) bleeding, anemia, pediatric care, and pregnancy and delivery. The expert ...

see more →

Patient Education  1 results see all →